東方支付集團控股(08613.HK)終止股份掉期協議
格隆匯11月27日丨東方支付集團控股(08613.HK)公佈,於2020年9月8日,東方支付及中國新經濟投資(00080.HK)訂立股份掉期協議。於2020年11月27日,東方支付與中國新經濟經公平磋商後訂立一份終止契據,以終止股份掉期協議,據此,自終止契據日期起,股份掉期協議須終止並對東方支付及中國新經濟不再有約束力。
由於股份掉期協議如上文所披露已通過終止契據終止,完成以及建議以東方支付一般授權配發及發行東方支付認購股份將不會如股份掉期協議初步預期般進行,因此,視作出售及東方支付集團於中國支付通集團賬目可能終止綜合入賬將不會落實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.